Wendy future of retail top

COVID-19 pill

Merck reports experimental COVID-19 pill cut deaths, hospitalizations in half when given early

Merck reports experimental COVID-19 pill cut deaths, hospitalizations in half when given early

KENILWORTH, N.J. —Merck announced Friday that it has developed an experimental COVID-19 pill that is said to reduced hospitalizations and deaths by half in people recently infected with the coronavirus. The company said that it would soon ask health officials in the U.S. and around the world to authorize its use. If cleared, Merck’s drug

PP_1170x120_10-25-21